Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The history shows a new revision v3.5.4 added and the previous revision v3.5.3 removed, indicating the study record has been refreshed to the latest version.
    Difference
    0.1%
    Check dated 2026-05-15T05:53:27.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A site release/version label on the page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a platform change rather than an update to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:18.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page history.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:52.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added updated Study Status and Contacts/Locations sections (version 59, published 2026-03-25) and a deletion on 2026-02-17.
    Difference
    0.3%
    Check dated 2026-03-26T11:31:42.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:13.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 is added to the version history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:22.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.